JF
ABCL icon

Jump Financial’s AbCellera Biologics ABCL Stock Holding History

Jump Financial’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Buy
126,000
+27,400
+28% +$134K 0.01% 1201
2026
Q1 		$344K Buy
98,600
+17,329
+21% +$62.4K ﹤0.01% 1420
2025
Q4 		$278K Sell
81,271
-594,329
-88% -$2.65M ﹤0.01% 1594
2025
Q3 		$3.4M Buy
+675,600
New +$2.98M 0.04% 531
2024
Q2 		– Sell
-221,913
Closed -$1.01M – 1744
2024
Q1 		$1.01M Sell
221,913
-25,684
-10% -$131K 0.03% 804
2023
Q4 		$1.41M Sell
247,597
-26,905
-10% -$125K 0.05% 533
2023
Q3 		$1.26M Sell
274,502
-107,124
-28% -$652K 0.05% 563
2023
Q2 		$2.47M Buy
381,626
+289,626
+315% +$1.98M 0.09% 314
2023
Q1 		$694K Buy
+92,000
New +$835K 0.03% 757
2022
Q4 		– Sell
-230,400
Closed -$2.28M – 1518
2022
Q3 		$2.28M Sell
230,400
-42,212
-15% -$463K 0.09% 339
2022
Q2 		$2.9M Buy
272,612
+23,712
+10% +$201K 0.12% 222
2022
Q1 		$2.43M Buy
248,900
+194,800
+360% +$1.84M 0.1% 240
2021
Q4 		$774K Buy
54,100
+13,553
+33% +$206K 0.05% 481
2021
Q3 		$813K Sell
40,547
-76,253
-65% -$1.35M 0.06% 345
2021
Q2 		$2.57M Buy
+116,800
New +$3.22M 0.25% 69

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Jump Financial's ABCL Position: Q2 2026 in Review

Jump Financial increased its AbCellera Biologics (ABCL) stake by 28% in Q2 2026, buying an estimated $134K and bringing the position to 126,000 shares worth $989K. The position accounts for 0.01% of the portfolio, ranked #1201.

Jump Financial first reported a position in ABCL in Q2 2021 and has held it in 15 quarters since. The position peaked at $3.4M in Q3 2025. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Jump Financial held 126,000 shares of AbCellera Biologics worth $989K as of Q2 2026.
  • Jump Financial bought 27,400 AbCellera Biologics shares in Q2 2026, an estimated $134K.
  • AbCellera Biologics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1201 holding.
  • Jump Financial first reported a position in AbCellera Biologics in Q2 2021 and has held it in 15 quarters since.
  • Jump Financial's AbCellera Biologics position peaked at $3.4M in Q3 2025.
  • 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.